Hookworm Infection Clinical Trial
Official title:
Efficacy and Nutritional Assessment Following Albendazole and Combined Albendazole/Ivermectin Treatment for Intestinal Helminth Infections in Rural Guatemalan Schoolchildren
The aim of this study is to compare the efficacy and impact on growth of two drug treatments against intestinal worms in schoolchildren from a rural area of Guatemala. According to the World Bank, these intestinal worms are one of the top causes of childhood health problems in many areas of the developing world (The World Bank, 1993). Infected children are more likely to have inadequate nutrition due to the worm infections and are more likely to be shorter in height and weigh less than children who are not infected. After collecting height and weight information, we will split the children into two groups. One group will receive albendazole and the other group will receive combined albendazole/ivermectin. Both groups will be receiving albendazole, the current standard of care treatment. Ivermection is expected to improve efficacy and nutritional benefit as well as add increased scope of treatment for the worm Strongyloides, and ectoparasites such as scabies and head lice. Both treatment regimens and the combination have been used millions of times in the developing world and are safe to use. Co-administration of drugs would be a more efficient use of the opportunity to access schoolchildren and provide deworming treatment.
Status | Completed |
Enrollment | 550 |
Est. completion date | March 2005 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 5 Years to 12 Years |
Eligibility |
Inclusion Criteria: Children will be eligible to participate in the study if they are between 5 and 12 years of age, are students in schools selected for study, and if parental consent and child assent for participation has been obtained. Exclusion Criteria: those not fitting criteria above |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Guatemala | Various elementary schools | Poptun | Peten |
Lead Sponsor | Collaborator |
---|---|
Centers for Disease Control and Prevention | Universidad del Valle, Guatemala |
Guatemala,
Horton J, Witt C, Ottesen EA, Lazdins JK, Addiss DG, Awadzi K, Beach MJ, Belizario VY, Dunyo SK, Espinel M, Gyapong JO, Hossain M, Ismail MM, Jayakody RL, Lammie PJ, Makunde W, Richard-Lenoble D, Selve B, Shenoy RK, Simonsen PE, Wamae CN, Weerasooriya MV. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology. 2000;121 Suppl:S147-60. Review. — View Citation
Stephenson LS, Latham MC, Ottesen EA. Global malnutrition. Parasitology. 2000;121 Suppl:S5-22. Review. — View Citation
Stephenson LS, Latham MC, Ottesen EA. Malnutrition and parasitic helminth infections. Parasitology. 2000;121 Suppl:S23-38. Review. — View Citation
World Health Organization, 1992. Health of school children: treatment of intestinal helminths and schistosomiasis. Geneva: WHO.
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | efficacy against geohelminths (stool egg count) | |||
Primary | height increase | |||
Primary | weight increase | |||
Secondary | ectoparasite examination |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03278431 -
Triple Combinations Against Hookworm Infections in Lao
|
Phase 4 | |
Completed |
NCT01717950 -
Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults
|
Phase 1 | |
Completed |
NCT02143518 -
Safety and Immunogenicity Study of Na-GST-1 With or Without CpG
|
Phase 1 | |
Completed |
NCT02126462 -
Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults
|
Phase 1 | |
Completed |
NCT01261130 -
Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults
|
Phase 1 | |
Completed |
NCT01385189 -
Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant
|
Phase 1 | |
Terminated |
NCT00473967 -
Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults
|
Phase 1 | |
Completed |
NCT00603889 -
Development of a Skin Test for the Na-ASP-2 Hookworm Antigen
|
N/A | |
Completed |
NCT02839161 -
Study of Co-administered Na-APR-1 (M74) and Na-GST-1 in Gabonese Children
|
Phase 1 | |
Completed |
NCT02476773 -
Study of Na-APR-1 (M74)/Alhydrogel® Co-administered With Na-GST-1/Alhydrogel in Brazilian Adults
|
Phase 1 | |
Recruiting |
NCT01940757 -
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
|
Phase 1 | |
Completed |
NCT03373214 -
Na-GST-1/Alhydrogel With or Without CpG 10104 in Gabonese Adults
|
Phase 1 | |
Completed |
NCT00939198 -
Prevalence of Hookworm Infection and Community Preparedness for Hookworm Vaccine Trials in Endemic Areas of Brazil
|
N/A | |
Active, not recruiting |
NCT02262403 -
Hookworm Immune Regulation Project
|
N/A | |
Completed |
NCT00120081 -
Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection
|
Phase 1 | |
Recruiting |
NCT05914363 -
Evaluating Impact of Improved Floors on Health
|
N/A |